Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth CorpfiledCriticalWyeth Corp
Publication of MY142635ApublicationCriticalpatent/MY142635A/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents
(AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
THE USE OF AN AMINOALKYL GLUCOSAMINE PHOSPHATE COMPOUND, OR A DERIVATIVE OR ANALOG THEREOF, IN COMBINATION WITH A CYTOKINE OR LYMPHOKINE SUCH AS GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR OR INTERLEUKIN-12, IS USEFUL AS AN ADJUVANT COMBINATION IN AN ANTIGENIC COMPOSITION TO ENHANCE THE ~E RESPONSE IN A VERTEBRATE HOST TO A SELECTED ANTIGEN.
Vaccine composition, use of enteroemorrhagic escherichia coli cell culture supernatant (ehec), and methods for generating an immune response in a mammal against a secreted enteroemorrhagic escherichia coli (ehec) antigen, and enteroemorrhagic 0157: h7 (ehec 0157) : h7) secreted, and for reduction of colonization of enteroemorrhagic escherichia coli (ehec) in a ruminant